Protection against concanavalin A-induced murine liver injury by the organic germanium compound, propagermanium - PubMed (original) (raw)
Protection against concanavalin A-induced murine liver injury by the organic germanium compound, propagermanium
Y Ishiwata et al. Scand J Immunol. 1998 Dec.
Free article
Abstract
Propagermanium (3-oxygermylpropionic acid polymer) is an organic germanium compound that activates the immune system. In this study, we investigated the action of propagermanium on T-cell-mediated murine hepatic injury induced by concanavalin A (Con A). Oral administration of propagermanium inhibited the development of liver injury about 10 h after ConA injection. Histological analysis demonstrated that propagermanium attenuated the extent of liver damage compared with controls, reducing infiltration by leucocytes, especially CD11b-positive cells. Infiltration by CD4-positive cells was not affected. Tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma are crucial for the development of hepatitis in this model. Propagermanium treatment induced significant inhibition of subsequent TNF-alpha production about 10 h after Con A injection, without affecting IFN-gamma, interleukin (IL)-10, IL-4 and IL-12 production. This effect on TNF-production coincided with the inhibition of aminotransferase activity late in the progression of Con A-induced liver injury. These facts suggest that this compound affects the macrophages (Mphi) function in the liver sinusoid. Therefore, Mphi were cultured with liver sinusoidal endothelial cells (SEC) and the effect of propagermanium on TNF-alpha production in the presence of IFN-gamma was determined. TNF-alpha production was reduced significantly in the coculture of Mphi and SEC when Mphi was treated with propagermanium. These results might explain the mechanisms by which propagermanium inhibits Con-A-induced liver injury. That is, propagermanium improves hepatitis through mechanisms including the reduced production of TNF-alpha, without modification of Th1- and Th2-cell function.
Similar articles
- Hepatoprotective effect of propagermanium on Corynebacterium parvum and lipopolysaccharide-induced liver injury in mice.
Yokochi S, Ishiwata Y, Hashimoto H, Ninomiya F, Suzuki T. Yokochi S, et al. Scand J Immunol. 1998 Aug;48(2):183-91. doi: 10.1046/j.1365-3083.1998.00356.x. Scand J Immunol. 1998. PMID: 9716110 - 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
Jakubowski A, Sternak M, Jablonski K, Ciszek-Lenda M, Marcinkiewicz J, Chlopicki S. Jakubowski A, et al. Int Immunopharmacol. 2016 Feb;31:98-104. doi: 10.1016/j.intimp.2015.11.032. Epub 2015 Dec 17. Int Immunopharmacol. 2016. PMID: 26709075 - Propagermanium: a nonspecific immune modulator for chronic hepatitis B.
Hirayama C, Suzuki H, Ito M, Okumura M, Oda T. Hirayama C, et al. J Gastroenterol. 2003;38(6):525-32. doi: 10.1007/s00535-003-1098-7. J Gastroenterol. 2003. PMID: 12825127 Review. - Germane facts about germanium sesquioxide: I. Chemistry and anticancer properties.
Kaplan BJ, Parish WW, Andrus GM, Simpson JS, Field CJ. Kaplan BJ, et al. J Altern Complement Med. 2004 Apr;10(2):337-44. doi: 10.1089/107555304323062329. J Altern Complement Med. 2004. PMID: 15165414 Review.
Cited by
- The role of germanium in diseases: exploring its important biological effects.
Luo X, Sun J, Kong D, Lei Y, Gong F, Zhang T, Shen Z, Wang K, Luo H, Xu Y. Luo X, et al. J Transl Med. 2023 Nov 8;21(1):795. doi: 10.1186/s12967-023-04643-0. J Transl Med. 2023. PMID: 37940963 Free PMC article. Review. - Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder.
Kataoka K, Kono Y, Sugimoto M, Furuichi Y, Shichiri M, Tanaka Y. Kataoka K, et al. Exp Ther Med. 2010 Nov;1(6):1041-1047. doi: 10.3892/etm.2010.159. Epub 2010 Sep 29. Exp Ther Med. 2010. PMID: 22993638 Free PMC article. - Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.
Zhang XL, Quan QZ, Sun ZQ, Wang YJ, Jiang XL, Wang D, Li WB. Zhang XL, et al. World J Gastroenterol. 2001 Aug;7(4):569-71. doi: 10.3748/wjg.v7.i4.569. World J Gastroenterol. 2001. PMID: 11819832 Free PMC article. No abstract available. - The role of chemokines in hepatitis C virus-mediated liver disease.
Brass A, Brenndörfer ED. Brass A, et al. Int J Mol Sci. 2014 Mar 18;15(3):4747-79. doi: 10.3390/ijms15034747. Int J Mol Sci. 2014. PMID: 24646914 Free PMC article. Review. - Blockade of CCR2 ameliorates progressive fibrosis in kidney.
Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H. Kitagawa K, et al. Am J Pathol. 2004 Jul;165(1):237-46. doi: 10.1016/S0002-9440(10)63292-0. Am J Pathol. 2004. PMID: 15215179 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials